GDTC
Price
$0.91
Change
+$0.01 (+1.11%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
10.69M
22 days until earnings call
Intraday BUY SELL Signals
HCWB
Price
$1.11
Change
-$0.05 (-4.31%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
2.13M
22 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GDTC vs HCWB

GDTC vs HCWB Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
GDTC vs. HCWB commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GDTC is a Hold and HCWB is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for GDTC with price predictions
Oct 21, 2026

GDTC in upward trend: price expected to rise as it breaks its lower Bollinger Band on October 12, 2026

GDTC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 24 of 27 cases where GDTC's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

GDTC moved above its 50-day moving average on October 21, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +6.04% 3-day Advance, the price is estimated to grow further. Considering data from situations where GDTC advanced for three days, in 114 of 133 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 31 of 37 cases where GDTC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 84%.

The Momentum Indicator moved below the 0 level on October 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GDTC as a result. In 64 of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.

The Moving Average Convergence Divergence Histogram (MACD) for GDTC turned negative on October 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In 34 of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at 83%.

The 10-day moving average for GDTC crossed bearishly below the 50-day moving average on October 19, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GDTC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 68 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.139) is normal, around the industry mean (2.988). P/E Ratio (0.000) is within average values for comparable stocks, (-1.158). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (123.903) among similar stocks. P/S Ratio (36.765) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 76 (best 1 - 100 worst), indicating slightly worse than average price growth. GDTC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GDTC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for HCWB with price predictions
Oct 21, 2026

HCWB's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for HCWB turned positive on October 19, 2026. Looking at past instances where HCWB's MACD turned positive, the stock continued to rise in 40 of 43 cases over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

Following a +5.98% 3-day Advance, the price is estimated to grow further. Considering data from situations where HCWB advanced for three days, in 131 of 167 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.

HCWB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HCWB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for HCWB entered a downward trend on October 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 51 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.287) is normal, around the industry mean (2.988). P/E Ratio (-0.070) is within average values for comparable stocks, (-1.158). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (123.903) among similar stocks. P/S Ratio (0.232) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 94 (best 1 - 100 worst), indicating slightly worse than average price growth. HCWB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HCWB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

TECHNICAL ANALYSIS
Technical Analysis
GDTCHCWB
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
N/A
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 7 days ago
78%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (GDTC: $0.90 vs. HCWB: $1.16)
Brand notoriety: GDTC and HCWB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GDTC: 17% vs. HCWB: 13%
Market capitalization -- GDTC: $10.87M vs. HCWB: $2.06M
GDTC [@Biotechnology] is valued at $10.87M. HCWB’s [@Biotechnology] market capitalization is $2.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $135.64B. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GDTC’s FA Score shows that 0 FA rating(s) are green while HCWB’s FA Score has 1 green FA rating(s).

  • GDTC’s FA Score: 0 green, 5 red.
  • HCWB’s FA Score: 1 green, 4 red.
According to our system of comparison, HCWB is a better buy in the long-term than GDTC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GDTC’s TA Score shows that 3 TA indicator(s) are bullish while HCWB’s TA Score has 4 bullish TA indicator(s).

  • GDTC’s TA Score: 3 bullish, 5 bearish.
  • HCWB’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, HCWB is a better buy in the short-term than GDTC.

Price Growth

GDTC (@Biotechnology) experienced а +7.56% price change this week, while HCWB (@Biotechnology) price change was -0.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.10%. For the same industry, the average monthly price growth was -18.18%, and the average quarterly price growth was -15.20%.

Reported Earning Dates

GDTC is expected to report earnings on Nov 13, 2026.

HCWB is expected to report earnings on Nov 13, 2026.

Industries' Descriptions

@Biotechnology (-1.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
GDTC
Daily Signal:
Gain/Loss:
HCWB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

GDTC and

Correlation & Price change

A.I.dvisor indicates that over the last year, GDTC has been loosely correlated with HCWB. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if GDTC jumps, then HCWB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GDTC
1D Price
Change %
GDTC100%
+3.68%
HCWB - GDTC
34%
Loosely correlated
-0.85%
CVKD - GDTC
29%
Poorly correlated
-1.92%
QSI - GDTC
28%
Poorly correlated
+6.03%
ADIL - GDTC
27%
Poorly correlated
+7.59%
GRCE - GDTC
27%
Poorly correlated
-0.51%
More

HCWB and

Correlation & Price change

A.I.dvisor indicates that over the last year, HCWB has been loosely correlated with APLM. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if HCWB jumps, then APLM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HCWB
1D Price
Change %
HCWB100%
-0.85%
APLM - HCWB
45%
Loosely correlated
-1.80%
GDTC - HCWB
35%
Loosely correlated
+3.68%
IVVD - HCWB
34%
Loosely correlated
+0.42%
GHRS - HCWB
32%
Poorly correlated
-1.33%
XLO - HCWB
30%
Poorly correlated
-1.29%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RENT2.180.16
+7.92%
Rent the Runway
RH128.018.27
+6.91%
RH
FMS21.560.15
+0.70%
Fresenius Medical Care AG
HBCP59.800.33
+0.55%
Home Bancorp
CHSN0.85-0.03
-3.04%
Chanson International Holding